Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study.
Publisher Correction: BMC Infectious Diseases (2022) 22:793 https://doi.org/10.1186/s12879-02... In the original publication of this article [[1]] the footnotes of Figure 1 were accidentally omitted during the publication process. 1Patients affected by haematological malignancies/autoimmune diseases...
| Published in: | BMC Infectious Diseases Vol. 22; no. 1; pp. 1 - 4 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
BioMed Central
11/25/2022
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160423491&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 160423491 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14712334 1CHU jtl: BMC Infectious Diseases issn: 14712334 maglogo: N pubinfo: dt: 11/25/2022 vid: 22 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 160423491 160423491 NLM36434528 10.1186/s12879-022-07871-9 NLM36434528 160423491 ppf: 1 ppct: 3 formats: tig: atl: Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study. aug: au: Scaglione, Vincenzo Rotundo, Salvatore Marascio, Nadia De Marco, Carmela Lionello, Rosaria Veneziano, Claudia Berardelli, Lavinia Quirino, Angela Olivadese, Vincenzo Serapide, Francesca Tassone, Bruno Morrone, Helen Linda Davoli, Chiara La Gamba, Valentina Bruni, Andrea Cesana, Bruno Mario Matera, Giovanni Russo, Alessandro Costanzo, Francesco Saverio Viglietto, Giuseppe affil: Chair of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, "Magna Græcia" University, Viale Europa, Loc. Germaneto, 88100, Catanzaro, Italy sug: ab: Publisher Correction: BMC Infectious Diseases (2022) 22:793 https://doi.org/10.1186/s12879-02... In the original publication of this article [[1]] the footnotes of Figure 1 were accidentally omitted during the publication process. 1Patients affected by haematological malignancies/autoimmune diseases or treated with immunosuppressive drugs or transplant receivers; 2First choice in patients with eGFR > 30 ml/min and no major drug interactions; 3Useful in patients with eGFR > 30 ml/min if major drug interactions contraindicate nirmatrelvir/ritonavir or in patients with dysphagia; 4For use in patients with severe renal insufficiency and/or partially immunised (i.e., previous SARS-CoV-2 infection, vaccination course incomplete or completed more than 6 months before); 5mAbs therapy was chosen considering local epidemiology of variants of concern Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. pubtype: Academic Journal doctype: Journal Article ougenre: Unknown language: English refInfo: holdings: @attributes: islocal: N |
|---|